117 related articles for article (PubMed ID: 1682474)
1. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells.
Ohki K; Kishi Y; Nishino Y; Sumiya M; Kimura T; Goto T; Nakai M; Ikuta K
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1233-40. PubMed ID: 1682474
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human immunodeficiency virus type 1 infectivity by replacing the region including Env derived from defective particles with an ability to form particle-mediated syncytia in CD4+T cells.
Kinomoto M; Mukai T; Li YG; Iwabu Y; Warachit J; Palacios JA; Ibrahim MS; Tsuji S; Goto T; Ikuta K
Microbes Infect; 2004 Aug; 6(10):911-8. PubMed ID: 15310467
[TBL] [Abstract][Full Text] [Related]
3. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process.
Chowdhury MI; Koyanagi Y; Suzuki M; Kobayashi S; Yamaguchi K; Yamamoto N
Virus Genes; 1992 Jan; 6(1):63-78. PubMed ID: 1347963
[TBL] [Abstract][Full Text] [Related]
4. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
Kannagi M; Kuroda MJ; Maeda Y; Harada S
Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290
[TBL] [Abstract][Full Text] [Related]
6. HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro.
Busso M; Thornthwaite J; Resnick L
AIDS; 1991 Dec; 5(12):1425-32. PubMed ID: 1687645
[TBL] [Abstract][Full Text] [Related]
7. Syncytium forming capacity of HIV 1 strains in inhibited by pretreatment of CD4 expressing cells with 3'-azido-3'-deoxythymidine but not by alpha interferon.
Ruţă SM; Cernescu C
Rev Roum Virol; 1994; 45(3-4):171-83. PubMed ID: 7619738
[TBL] [Abstract][Full Text] [Related]
8. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric method to monitor the destruction of CD4+ cells following their fusion with HIV-infected cells.
Schols D; Pauwels R; Desmyter J; De Clercq E
Cytometry; 1990; 11(6):736-43. PubMed ID: 1696539
[TBL] [Abstract][Full Text] [Related]
10. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
[TBL] [Abstract][Full Text] [Related]
11. The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1.
Goto T; Ikuta K; Zhang JJ; Morita C; Sano K; Komatsu M; Fujita H; Kato S; Nakai M
Arch Virol; 1990; 111(1-2):87-101. PubMed ID: 1691624
[TBL] [Abstract][Full Text] [Related]
12. Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains.
Shieh JT; Martín J; Baltuch G; Malim MH; González-Scarano F
J Virol; 2000 Jan; 74(2):693-701. PubMed ID: 10623731
[TBL] [Abstract][Full Text] [Related]
13. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy.
Baba M; Schols D; Pauwels R; Nakashima H; De Clercq E
J Acquir Immune Defic Syndr (1988); 1990; 3(5):493-9. PubMed ID: 1691288
[TBL] [Abstract][Full Text] [Related]
14. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.
Ikuta K; Morita C; Nakai M; Yamamoto N; Kato S
Jpn J Cancer Res; 1988 Apr; 79(4):418-23. PubMed ID: 2898463
[TBL] [Abstract][Full Text] [Related]
15. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.
LaBonte JA; Patel T; Hofmann W; Sodroski J
J Virol; 2000 Nov; 74(22):10690-8. PubMed ID: 11044113
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin.
Momota K; Kaneko I; Kimura S; Mitamura K; Shimada K
Biochem Biophys Res Commun; 1991 Aug; 179(1):243-50. PubMed ID: 1715691
[TBL] [Abstract][Full Text] [Related]
17. Sulfated colominic acid: an antiviral agent that inhibits the human immunodeficiency virus type 1 in vitro.
Yang DW; Ohta Y; Yamaguchi S; Tsukada Y; Haraguchi Y; Hoshino H; Amagai H; Kobayashi I
Antiviral Res; 1996 Jun; 31(1-2):95-104. PubMed ID: 8793013
[TBL] [Abstract][Full Text] [Related]
18. Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C.
Mohagheghpour N; Chakrabarti R; Stein BS; Gowda SD; Engleman EG
J Biol Chem; 1991 Apr; 266(11):7233-8. PubMed ID: 1826686
[TBL] [Abstract][Full Text] [Related]
19. Fusion from without directed by human immunodeficiency virus particles.
Clavel F; Charneau P
J Virol; 1994 Feb; 68(2):1179-85. PubMed ID: 8289347
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia.
Wünschmann S; Stapleton JT
J Clin Microbiol; 2000 Aug; 38(8):3055-60. PubMed ID: 10921977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
